Cary Street Partners Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
MIP
CI
Cary Street Partners Asset Management's TAK Position: Q2 2023 in Review
Cary Street Partners Asset Management sold out of Takeda Pharmaceutical (TAK) in Q2 2023, closing a stake of 70 shares — an estimated $1.15K sold.
Cary Street Partners Asset Management first reported a position in TAK in Q3 2022 and held it in 3 quarters. The position peaked at $1.15K in Q1 2023. 311 funds tracked by Wall St. Rank hold TAK as of Q2 2023.
- Cary Street Partners Asset Management reported no remaining Takeda Pharmaceutical position as of Q2 2023 after selling out during the quarter.
- Cary Street Partners Asset Management sold 70 Takeda Pharmaceutical shares in Q2 2023, an estimated $1.15K.
- Cary Street Partners Asset Management first reported a position in Takeda Pharmaceutical in Q3 2022 and held it in 3 quarters.
- Cary Street Partners Asset Management's Takeda Pharmaceutical position peaked at $1.15K in Q1 2023.
- 311 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2023.
Based on Cary Street Partners Asset Management's 13F filing for Q2 2023, filed 10 Aug 2023.